MOVANTIG Trademark

Trademark Overview

On Monday, May 6, 2013, a trademark application was filed for MOVANTIG with the United States Patent and Trademark Office. The USPTO has given the MOVANTIG trademark a serial number of 85924236. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, March 30, 2016. This trademark is owned by AstraZeneca AB. The MOVANTIG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
movantig

General Information

Serial Number85924236
Word MarkMOVANTIG
Filing DateMonday, May 6, 2013
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, March 30, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 13, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Wednesday, March 30, 2016ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, March 30, 2016ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 2, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, September 2, 2015INQUIRY TO SUSPENSION E-MAILED
Wednesday, September 2, 2015SUSPENSION INQUIRY WRITTEN
Tuesday, September 1, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, February 18, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 18, 2015LETTER OF SUSPENSION E-MAILED
Wednesday, February 18, 2015SUSPENSION LETTER WRITTEN
Tuesday, February 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 9, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 15, 2014NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, August 15, 2014INQUIRY TO SUSPENSION E-MAILED
Friday, August 15, 2014SUSPENSION INQUIRY WRITTEN
Wednesday, August 13, 2014LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, August 11, 2014ASSIGNED TO LIE
Monday, February 10, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 10, 2014LETTER OF SUSPENSION E-MAILED
Monday, February 10, 2014SUSPENSION LETTER WRITTEN
Saturday, February 8, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 7, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 7, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 26, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 26, 2013NON-FINAL ACTION E-MAILED
Monday, August 26, 2013NON-FINAL ACTION WRITTEN
Friday, August 23, 2013ASSIGNED TO EXAMINER
Monday, May 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 9, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

movantig diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal